Bioresorbable plastic stents will be a big story in 2014

One of the biggest stories in medical plastics in 2014 will be the increasing use of bioresorbable drug-eluting stents for treatment of coronary artery disease.

Abbott Laboratories (Abbott Park, IL) is expanding U.S. trials for its Absorb Bioresorbable Vascular Scaffold (BVS), a mesh tube made of polylactide. The purpose of the device is to open a blocked blood vessel, restore blood flow while preventing any immediate further hardening of the artery, and then dissolve and leave the body. All that remains are two metallic markers that allow physicians to see precisely where the stent had been placed.

Read more